FearLess in NeuroOncology

FearLess in Neuro-Oncology

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

The purpose of this study is to assess the feasibility, acceptability, appropriateness (FAA) of recruitment methods, study population, and waitlist design to finalize the protocol of FearLess, a psychological intervention targeting fear of cancer recurrence in primary malignant brain tumor patients and caregivers. Eligible participants (N=112) will be randomized to either: 1) immediate intervention or 2) delayed treatment control. Assessments will take place at baseline, Week 12, and Week 26.

Inclusion Criteria:

Patients:

• Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
• >2 weeks post-cranial resection or biopsy
• Elevated Fear of Recurrence Distress Rating
• Primarily English speaking
• >/= 18 years of age at the time of enrollment

Caregivers:

• nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
• Elevated Fear of Recurrence Distress Rating
• Primarily English speaking
• >/= 18 years of age at the time of enrollment

Exclusion Criteria:

Patient / Caregiver Exclusion:

• Cognitive impairment that might prohibit active intervention engagement
• Inability to understand and provide informed consent
• Inability to attend virtual sessions due to unstable or no internet connection